Approved September 1997
Diabetes / Endocrinology
The U.S. Food and Drug Administration has authorized Duramed Pharmaceuticals, Inc. to market Glipizide tablets, a treatment for diabetes, in the 5 mg and 10 mg strengths. The FDA granted Duramed's Glipizide tablets a therapeutic equivalency rating of AB, designating Duramed's Glipizide tablets as completely interchangeable with Glucotrol (R) tablets for all new and refill prescriptions.
The Glipizide Tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.